B
BioSerenity
Biotech & Life Sciences · Paris, France · Founded 2014
Leading global providers of remote diagnostic solutions MoreLess
BioSerenity is a global startup operating in the healthcare technology sector, specifically focusing on sleep research and electroencephalogram (EEG) devices. Their primary offerings include a fully customizable software for managing sleep and EEG labs, and a range of innovative, connected medical devices designed to make EEGs more accessible.
Their software solution includes features for scheduling, home sleep test (HST) processing, and shipping, making it a comprehensive tool for labs. Their EEG devices, including their featured product, the ICECap, are designed for easy use and quick setup, making brainwave acquisition more efficient and user-friendly.
In addition to their products, BioSerenity also offers their vast real-world database for device and algorithm development, providing a valuable resource for researchers and developers in the field.
The company's business model revolves around selling their software and devices to sleep and EEG labs, hospitals, and research institutions. They also generate revenue by providing access to their database and conducting sleep-focused research studies through their BioSerenity Research Group.
In summary, BioSerenity is a tech startup providing innovative solutions for sleep research and EEG labs, with a business model based on product sales, data access, and research services.
Keywords: Sleep Research, EEG Devices, Lab Management Software, Medical Devices, Brainwave Acquisition, Real-World Database, Algorithm Development, Global Company, Sleep-Focused Research Studies, Healthcare Technology.
Company overview
BioSerenity company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2014
- Headquarters
- Paris, France
- Employees
- 273
- Open positions
- 17
- Dealroom signal
- 73.2
- Investment activity
- 1 companies · latest Apr 2024
- Capital deployed
- $7.7M
- Preferred round
- EARLY VC
Valuation & funding
BioSerenity funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Nov 2023 | $26M | $358M | Jolt Capital | ↗ |
| FundingOther financing | Feb 2022 | $0 | — | SCOR | — |
| FundingOther financing | Nov 2019 | $0 | — | SCOR | — |
| SERIES BOther financing | Jun 2019 | $72M | $286M | Bpifrance · Eurazeo · Dassault Systemes · LBO France | ↗ |
| SUPPORT PROGRAMOther financing | Aug 2018 | $2K | — | EIT Health | — |
| SERIES AOther financing | Sep 2017 | Bpifrance · Eurazeo · LBO France | ↗ | ||
| SUPPORT PROGRAMOther financing | Jul 2016 | EIT Health | — | ||
| SEEDOther financing | Nov 2015 | Eurazeo · Kurma Partners | ↗ | ||
| SEEDOther financing | Sep 2014 | Undisclosed | — | ||
| SPINOUTOther financing | Jan 2014 | Sorbonne University · Pitié-Salpêtrière University Hospital | — |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $5.3M | 0% | 273 |
| 2025 | $5.3M | 0% | 264 |
| 2024 | $5.3M | 0% | 267 |
| 2023 | $5.3M | 0% | 335 |
| 2022 | $5.3M | 0% | 369 |
| 2021 | $5.3M | 0% | 342 |
| 2020 | $5.3M | — | 318 |
Growth signals
BioSerenity website traffic
Latest recorded traffic for BioSerenity is 6.2K monthly website visits, down 1.6% over the last three months. BioSerenity's team grew 3.4% over the past year.
Hiring
Open positions at BioSerenity
Current openings linked to this company in Dealroom.
Comparisons
BioSerenity compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Capital deployed
BioSerenity investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Talent graph
BioSerenity's talent
Source: Dealroom Talent Intelligence.
Investors
10 investors on BioSerenity's cap table
Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.
Global footprint
Where BioSerenity has talent and traffic
team presence
In the news
Latest news about BioSerenity
Recent press, funding announcements, and product moves mentioning BioSerenity — open to read from the original sources.
Market sentiment
What the market is saying about BioSerenity
An AI-synthesized read of the highest-engagement posts about BioSerenity on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BioSerenity’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.